Literature DB >> 10638690

Moderate hyperhomocysteinemia and cardiovascular disease.

M Y Tsai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10638690     DOI： 10.1016/s0022-2143(00)70016-3

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  4 in total

1.  Who's afraid of homocysteine?

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

2.  Immediate and long-term high levels of plasma homocysteine after extracorporeal shock wave lithotripsy in patients with renal stone disease.

Authors:  Erkan Demir; Volkan Izol; I Atilla Aridogan; Saime Paydas; Zuhtu Tansug; Ugur Erken
Journal:  Clin Exp Nephrol       Date:  2014-05-28       Impact factor: 2.801

3.  Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era.

Authors:  Michael Y Tsai; Catherine M Loria; Jing Cao; Yongin Kim; David Siscovick; Pamela J Schreiner; Naomi Q Hanson
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

4.  Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study.

Authors:  Michael Y Tsai; Catherine M Loria; Jing Cao; Yongin Kim; David S Siscovick; Pamela J Schreiner; Naomi Q Hanson
Journal:  Mol Genet Metab       Date:  2009-06-06       Impact factor: 4.797
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.